Market
Will Absci reduce hardware costs by at least 10% with AMD tech by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Absci Corporation's financial reports or official press releases
Story
AMD Invests $20M in AI-Driven Absci Structured as PIPE to Boost Drug Discovery Efforts
Jan 8, 2025, 11:50 AM
Advanced Micro Devices (AMD) has made a $20 million investment in Absci Corporation (ABSI), a company focused on AI-driven drug discovery. This strategic investment, reported by the Wall Street Journal, is part of AMD's initiative to market its AI semiconductors to the healthcare sector. The investment is structured as a private investment in public equity (PIPE) and aims to assist Absci in reducing its hardware costs by migrating some of its workloads to AMD's technology. This move underscores AMD's commitment to expanding its presence in the healthcare industry through innovative AI applications.
View original story
Similar markets
More than 3 new partnerships • 25%
2 to 3 new partnerships • 25%
1 new partnership • 25%
No new partnerships • 25%
No clear comparison available • 25%
Nvidia GPUs outperform AMD GPUs • 25%
AMD GPUs outperform Nvidia GPUs • 25%
Performance is similar • 25%
Yes • 50%
No • 50%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Proceed with IPO • 25%
Acquisition by SoftBank and Arm • 25%
Acquisition by another company • 25%
Remain independent • 25%